HOME >> BIOLOGY >> NEWS
Impact of forest certification in developing countries examined

New Haven, Conn. -- A market-based system to protect global forests is struggling to take root in developing countries, according to a recently published book in the Yale School of Forestry & Environmental Studies Publication Series.

"Confronting Sustainability: Forest Certification in Developing and Transitioning Countries," edited by Benjamin Cashore (Yale University), Fred Gale (University of Tasmania, Australia), Errol Meidinger (SUNY Buffalo) and Deanna Newsom (Rainforest Alliance), assesses the effectiveness of forest certification programs that give consumers, retailers and manufacturers the opportunity to purchase products derived from environmentally and socially responsible forest operations.

The 16-country comparative, historical analysis, spanning 622 pages, reveals that existing interest and commitments from North American and European markets have not been strong enough to influence forest management choices significantly in some of the world's most environmentally sensitive forests.

The editors argue that the success of forest certification depends on a heightened level of concern and awareness on the part of the world's wealthiest consumers of forest products, whose consumption habits currently feed tropical forest destruction. For example, an increased demand for certified forest products could have a huge impact on China's use of timber, since the bulk of their products are destined for foreign markets.

Critical findings from the book emphasize a need for the increased commercial support of forest certification, as firms undergoing the process are required to undertake critical improvements in their environmental and social practices.

In addition, forest certification programs have generated significant opportunities for public participation, exchange and learning among industrial, environmental and social organizations and indigenous peoples. For instance, forest certification has led to a
'"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
1-Sep-2006


Page: 1 2

Related biology news :

1. Impressive new Impact Factors for BioMed Centrals open-access journals
2. Genome Biologys first Impact Factor 9.71
3. New study warns limited carbon market puts 20 percent of tropical forest at risk
4. Tropical insects go the distance to inform rainforest conservation
5. Rain forest protection works in Peru
6. Smithsonian scientists show differing patterns of rainforest biodiversity
7. Lost forest yields several new species
8. Increase in creeping vines signals major shift in southern US forests
9. Loss of hemlocks will affect water dynamics in southern Appalachian forests
10. Greenlands ancient forests shed light on stability of ice sheet
11. Northern forests less effective than tropical forests in reducing global warming

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Impact forest certification developing countries examined

(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ... Competitive Profiles - NEC" report to their offering. ... will continue to supply a range of IT security ... company focus on the development of a Big Data ... in the Asia-Pacific region is ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a ... and services, and Morpho, a leading supplier of ... to produce the market,s most advanced biometrically-enabled time ... iSolved NXG time clock is setting a bold, ... labor data for the small and mid-size employer. ...
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
(Date:4/16/2015)... (PRWEB) April 16, 2015 Regis Technologies ... American Association for Cancer Research (AACR) annual meeting. Regis ... Convention Center, starting Saturday, April 18, in Philadelphia and ... claim to title of the oldest and largest organization ... fellowships and grants, and partners with survivors to promote ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 ... at Charlotte (UNC Charlotte) spin-out company, announced today ... Cooper, Ph.D., M.D., as Chief Operating Officer (COO). ... of experience in developing clinical diagnostic and biotechnology ... infectious disease. , Cooper’s extensive career transcends the ...
(Date:4/16/2015)... 16, 2015  In recognition of World Hemophilia Day, ... groups to illuminate more than 15 prominent landmarks red throughout ... Boston,s Zakim Bridge and Prudential Tower, ... Mercedes-Benz Superdome and Denver,s ... of April 17, and coincide with hemophilia community events in ...
(Date:4/16/2015)... April 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... U.S. joint venture with G-treeBNT (ReGenTree LLC) has ... clinical trial for the orphan disorder, neurotrophic keratopathy ... dry eye syndrome (DES) in the U.S.  Both ... RGN-259/GBT201, this year.  Each of these eye disorders ...
Breaking Biology Technology:Regis Technologies Joins American Association for Cancer Research Annual Meeting 2OncoTAb Names Dr. David L. Cooper as COO 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 3Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5
Cached News: